Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Becker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
The Annals of Pharmacotherapy|August 31, 2018
Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United StatesQuang A Le, Joel W Hay, Russell Becker, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literatureRussell Becker, Carole Dembek, Leigh Ann White, et al.
European Urology|May 14, 2021
Climate Change Impact of Virtual Urology MeetingsSunil H Patel, Kelsey Gallo, Russell Becker, et al.
The Journal of Urology|April 21, 2009
Bother related to bladder control and health care seeking behavior in adults in the United StatesJoshua S Benner, Russell Becker, Kristina Fanning, et al.
JAMA Network Open|April 4, 2022
Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UKMuhieddine Labban, Prokar Dasgupta, Chao Song, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 14, 2020
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressantKokuvi Atsou, Larry Ereshefsky, Mélanie Brignone, et al.
Urology|January 15, 2026
Reducing opioid utilization after ureteroscopy without compromising patient outcomes in a statewide quality improvement collaborativeWilson Sui, Suprita Krishna, Russell Becker, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
The Annals of Pharmacotherapy|August 31, 2018
Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United StatesQuang A Le, Joel W Hay, Russell Becker, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literatureRussell Becker, Carole Dembek, Leigh Ann White, et al.
European Urology|May 14, 2021
Climate Change Impact of Virtual Urology MeetingsSunil H Patel, Kelsey Gallo, Russell Becker, et al.
The Journal of Urology|April 21, 2009
Bother related to bladder control and health care seeking behavior in adults in the United StatesJoshua S Benner, Russell Becker, Kristina Fanning, et al.
JAMA Network Open|April 4, 2022
Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UKMuhieddine Labban, Prokar Dasgupta, Chao Song, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 14, 2020
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressantKokuvi Atsou, Larry Ereshefsky, Mélanie Brignone, et al.
Urology|January 15, 2026
Reducing opioid utilization after ureteroscopy without compromising patient outcomes in a statewide quality improvement collaborativeWilson Sui, Suprita Krishna, Russell Becker, et al.
Pageof 1